z-logo
open-access-imgOpen Access
CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer
Author(s) -
Jordi Remón,
Ana Collazo,
Beatriz Jiménez
Publication year - 2020
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2020.03.09
Subject(s) - medicine , lung cancer , immune system , cancer , first line , oncology , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom